Animal Health

Zoetis (NYSE: ZTS) shareholders may have a new reference point to be excited about, even after witnessing some favorable developments through the company's first quarter 2023 announcements. Even after outperforming other peers in the sector, such as Bausch Health Companies (NYSE...

Zoetis Inc (NYSE: ZTS) seems well-positioned in 2021 with the stock valuation offering an attractive entry point, according to BofA Securities. The Zoetis Analyst: Michael Ryskin upgraded the rating for Zoetis from Neutral to Buy, while maintaining a price target of $180. The Zoetis...

Elanco Animal Health Inc (NYSE: ELAN) in a filing with the U.S. Securities and Exchange Commission on Monday disclosed that German pharma and life sciences company Bayer AG (OTC: BAYRY) is offloading a substantial stake it holds in Elanco through a public offering and generate $1.6 billion in...

Zoetis Inc (NYSE: ZTS), a global leader in animal health products, continues to benefit from favorable industry trends — which is attracting the attention of investors and Wall Street analysts. The Analyst Morgan Stanley's David Risinger upgraded Zoetis' stock rating from Equal-...

IDEXX Laboratories, Inc. (NASDAQ: IDXX) hosted last week its annual Analyst Day presentation which prompted analysts at Bank of America to upgrade the stock and label it a "top dog." The firm's Derik de Bruin upgrades Idexx's stock rating from Neutral to Buy with an unchanged $175...

After a more than 15-percent gain in Zoetis Inc (NYSE: ZTS) since the start of 2017, analysts at Deutsche Bank see little incremental upside in the near-term. Gregg Gilbert downgraded Zoetis' stock from Buy to Hold with an unchanged $65 price target as it has handily outperformed the S&P...

If you own what statisticians dryly call a “companion animal,” then it's no surprise to you that the pet care industry is massive. The global market has reportedly been growing at a rate of four percent annually since 2008 – making it one of the few industrial sectors to see growth during the...